marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-14-2024
Inhibikase Therapeutics Financial Statements 2011-2024 | IKT
Annual Financial Statements Inhibikase Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
12.3 M | 3.25 M | 19.3 M | 54.7 M | - | - | - | - | - | - | - | - | - |
Shares |
5.33 M | 4.22 M | 18.2 M | 8.21 M | - | - | - | - | - | - | - | - | - |
Historical Prices |
2.3 | 0.77 | 1.06 | 6.7 | - | - | - | - | - | - | - | - | - |
Net Income |
-19 M | -18.1 M | -14.8 M | -2.85 M | -5.72 M | -2.15 M | - | - | - | - | - | - | - |
Revenue |
261 K | 123 K | 3.1 M | 698 K | 1.12 M | 4.04 M | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | 698 K | - | - | - | - | - | - | - | - | - |
Operating Income |
-20.1 M | -18.1 M | -14.8 M | -2.82 M | - | - | - | - | - | - | - | - | - |
Interest Expense |
1.06 M | 74.5 K | -19.9 K | 29.4 K | - | - | - | - | - | - | - | - | - |
EBITDA |
-19.9 M | -18.1 M | -14.8 M | - | -5.7 M | -2.12 M | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | 3.52 M | 6.82 M | 6.16 M | - | - | - | - | - | - | - |
General and Administrative Expenses |
6.73 M | 6.22 M | 6.51 M | 2.62 M | 4.27 M | 2.52 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Inhibikase Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
8.88 M | 7.54 M | 6.34 M | 6.19 M | 5.34 M | 5.23 M | 4.59 M | 4.22 M | 4.22 M | 4.22 M | 25.2 M | 25.2 M | 25.1 M | 12.2 M | 10.1 M | 10.1 M | 8.2 M | 8.18 M | 8.18 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-5.78 M | -4.96 M | -4.65 M | - | -4.6 M | -5.78 M | -4.48 M | - | -4.49 M | -4.64 M | -4.64 M | - | -4.47 M | -2.64 M | -2.64 M | - | -671 K | -422 K | -547 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | 79.6 K | 116 K | 64.5 K | - | 7.29 K | 6.55 K | 46 K | - | 328 K | 1.36 M | 1.41 M | - | 37.7 K | 220 K | 271 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-5.83 M | -5.05 M | -4.78 M | - | -4.77 M | -6.2 M | -4.71 M | - | -4.51 M | -4.64 M | -4.64 M | - | -4.47 M | -2.63 M | -2.63 M | - | -664 K | -414 K | -540 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
49.4 K | 90.9 K | 133 K | - | 174 K | 424 K | 237 K | - | 18.5 K | 5 | -5 | - | 157 | 7.81 K | 11.8 K | - | 6.89 K | 7.95 K | 7.42 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-5.82 M | -5.04 M | -4.78 M | - | -4.76 M | -6.04 M | -4.71 M | - | -4.51 M | -4.64 M | -4.64 M | - | -4.47 M | -2.63 M | -2.63 M | - | -664 K | -414 K | -540 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
1.64 M | 1.97 M | 2.03 M | - | 1.62 M | 1.78 M | 1.93 M | - | 1.54 M | 1.66 M | 1.67 M | - | 1.64 M | 1.61 M | 1.6 M | - | 581 K | 370 K | 528 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency